AnalystsDrew RanieriDrew Ranieri's Stock Forecasts
AnalystsDrew Ranieri
Analyst Ranking
Bottom 22%
#2838 out of 3583 analysts
Average Return
-1.9%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
Drew Ranieri's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Agiliti IncAGTI | +23.17% | $15.19 | $18.71 | 2021-05-17 - 2022-01-25 | Strong Buy |
Hill-Rom Holdings IncHRC | +12.63% | $138.47 | $155.96 | 2021-08-01 - 2021-12-10 | Strong Buy |
NeuroPace IncNPCE | +7.67% | $10.04 | $9.27 | 2022-01-06 - 2022-01-25 | Strong Sell |
Avanos Medical IncAVNS | +6.33% | $33.97 | $31.82 | 2021-08-03 - 2022-01-25 | Strong Sell |
Treace Medical Concepts IncTMCI | +1.08% | $17.63 | $17.82 | 2022-01-06 - 2022-01-25 | Strong Buy |
Drew Ranieri's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
NeuroPace IncNPCE | 1 | Strong Sell | $12.00 | +29.45% | Downgrades | 20 days ago |
Treace Medical Concepts IncTMCI | 2 | Strong Buy | $30.00 | +68.35% | Upgrades | 20 days ago |
Bioventus IncBVS | 1 | Strong Buy | $20.00 | +55.52% | Reinstates | 2 months ago |
Intuitive Surgical IncISRG | 2 | Hold | $325.00 | +23.04% | Maintains | 3 months ago |
Stevanato Group SpASTVN | 2 | Strong Buy | $28.00 | +58.64% | Maintains | 5 months ago |
Avanos Medical IncAVNS | 1 | Strong Sell | $41.00 | +28.85% | Maintains | 6 months ago |
Hill-Rom Holdings IncHRC | 1 | Strong Buy | $148.00 | -5.10% | Maintains | 6 months ago |
Stryker CorpSYK | 1 | Strong Buy | $300.00 | +20.35% | Maintains | 6 months ago |
Agiliti IncAGTI | 1 | Strong Buy | $21.00 | +12.24% | Initiates Coverage On | 8 months ago |
Haemonetics CorpHAE | 1 | Hold | $83.00 | +68.60% | Downgrades | 9 months ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.